Licensing Proposal

If we are interested in your proposal, we will contact you for details. Because it is difficult to guarantee the confidentiality of the information you may provide, please do not send us any confidential information.

Telephone*
  1. You agree that all disclosures on your part are completely voluntary and our review of your submission neither creates nor implies a confidential, fiduciary, employment or contractual relationship. Prosidion owes NO COMPENSATION, COMMISSION, OR ANY OTHER PAYMENT to you as a result of your submission.
  2. You agree that all information you are disclosing is non-confidential and non-proprietary. Prosidion shall not be liable for any disclosure of any information you submit.
  3. By submitting your information, you confirm that you have the right to disclose such information to us and your submission does not violate intellectual property, proprietary, contract or any other rights of any third party.
  4. You agree that you will not challenge or object, or assist any third party to challenge or object, to any use Prosidion may make of your submission and any information contained therein for any purpose, and you expressly waive any rights you may have to do so.
  5. By submitting your information, you confirm that you have read, understand and agree to Prosidion’s Terms of Use and Privacy Policy..
  6. You acknowledge that your personal information shall only be used by Prosidion to review all the information you submit and to contact or respond you.
Email address*
Address*
Website address
Company/Organisation Profile
Summary*
provide a NON-CONFIDENTIAL description of your compound or product (e.g., therapeutic area, product code or name , mechanism of action) and type of alliance you are seeking.
Current Stage of Development
(e.g. preclinical or clinical trial stage, under application for approval, etc.).
Intellectual Property Status
(e.g. patent applied for, provisional application, patent obtained, trademark applications or registrations, copyrights).
Contact Person*
Name of Company/Organisation*
(* = Required Field)

In-licensing

Prosidion’s strategy is to build a strong pipeline of first- or best-in-class compounds against validated target product profiles. Prosidion is looking for opportunities to expand its portfolio of projects and product candidates in the fields of type 2 diabetes and obesity. Companies or academic institutions with promising intellectual property that might be of interest are invited to contact the company using the form below.